Paul Tudor Jones II's position in GeneDx Holdings Corp is currently worth $5.74 Million. That's 0.07% of their equity portfolio (353rd largest holding). The first GeneDx Holdings Corp trade was made in Q2 2024. Since then Paul Tudor Jones II bought shares one more times and sold shares on one occasions. The stake costed the investor $3.55 Million, netting the investor a gain of 62% so far.